tiprankstipranks
Trending News
More News >
Aim Immunotech Inc. (AIM)
:AIM
US Market

AIM ImmunoTech (AIM) Ratios

Compare
883 Followers

AIM ImmunoTech Ratios

AIM's free cash flow for Q4 2024 was $0.84. For the 2024 fiscal year, AIM's free cash flow was decreased by $ and operating cash flow was $-129.67. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
26.69 1.68 26.69 74.61 36.58
Quick Ratio
26.69 1.72 26.69 74.61 36.58
Cash Ratio
19.88 0.63 19.88 47.69 34.94
Solvency Ratio
-10.65 -3.14 -10.65 -25.25 -4.73
Operating Cash Flow Ratio
-11.84 -2.46 -11.84 -20.75 -9.41
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 3.13M$ 5.41M$ 34.30M$ 49.39M$ 37.02M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.04 0.02 <0.01 0.04
Debt-to-Equity Ratio
0.02 0.07 0.02 <0.01 0.04
Debt-to-Capital Ratio
0.02 0.07 0.02 <0.01 0.04
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.05 1.89 1.05 1.01 1.05
Debt Service Coverage Ratio
0.00 0.00 0.00 -308.07 -22.14
Interest Coverage Ratio
0.00 0.00 0.00 -281.16 -22.55
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.02 0.01 0.02 <0.01 0.09
Net Debt to EBITDA
-0.60 0.15 1.32 1.75 2.78
Profitability Margins
Gross Profit Margin
-14029.79%79.21%-14029.79%-529.63%-394.48%
EBIT Margin
-14129.79%-15800.00%-14129.79%-14118.52%-8422.09%
EBITDA Margin
-14091.49%-15682.18%-14091.49%-13522.22%-7988.96%
Operating Profit Margin
-14129.79%-15800.00%-14129.79%-13954.07%-9295.71%
Pretax Profit Margin
-13790.78%-14337.62%-13790.78%-14168.15%-8834.36%
Net Profit Margin
-14954.61%-14337.62%-14954.61%-15935.56%-9974.23%
Continuous Operations Profit Margin
-13790.78%-14337.62%-13790.78%-14168.15%-8834.36%
Net Income Per EBT
108.44%100.00%108.44%112.47%112.90%
EBT Per EBIT
97.60%90.74%97.60%101.53%95.04%
Return on Assets (ROA)
-53.54%-149.44%-52.08%-37.28%-25.17%
Return on Equity (ROE)
-83.88%-283.00%-54.81%-37.82%-26.52%
Return on Capital Employed (ROCE)
-65.17%-297.47%-50.92%-33.03%-23.87%
Return on Invested Capital (ROIC)
-73.05%-291.42%-54.97%-37.13%-26.93%
Return on Tangible Assets
-56.78%-169.69%-54.70%-38.61%-25.77%
Earnings Yield
-546.32%-135.51%-140.71%-49.40%-28.52%
Efficiency Ratios
Receivables Turnover
0.08 0.17 0.08 0.08 0.15
Payables Turnover
52.85 <0.01 52.85 4.29 2.10
Inventory Turnover
0.00 -0.14 0.00 0.00 0.00
Fixed Asset Turnover
0.14 0.25 0.14 0.03 0.02
Asset Turnover
<0.01 0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Cash Conversion Cycle
1.94K -56.48K 4.33K 4.35K 2.34K
Days of Sales Outstanding
2.14K 2.14K 4.34K 4.44K 2.52K
Days of Inventory Outstanding
<0.01 -2.62K 0.00 0.00 0.00
Days of Payables Outstanding
192.92 55.99K 6.91 85.02 173.44
Operating Cycle
2.14K -485.12 4.34K 4.44K 2.52K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.34 -0.44 -0.34 -0.29 -0.33
Free Cash Flow Per Share
-0.34 -0.45 -0.34 -0.31 -0.34
CapEx Per Share
<0.01 0.01 <0.01 0.01 0.02
Free Cash Flow to Operating Cash Flow
1.02 1.03 1.02 1.05 1.06
Dividend Paid and CapEx Coverage Ratio
-59.44 -36.35 -59.44 -22.06 -17.43
Capital Expenditure Coverage Ratio
-59.44 -36.35 -59.44 -22.06 -17.43
Operating Cash Flow Coverage Ratio
-19.24 -29.62 -19.24 -93.72 -4.54
Operating Cash Flow to Sales Ratio
-114.24 -105.28 -114.24 -103.44 -63.61
Free Cash Flow Yield
-475.97%-102.24%-109.30%-33.52%-19.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.71 -0.74 -0.71 -2.02 -3.51
Price-to-Sales (P/S) Ratio
106.28 105.81 106.28 322.61 349.68
Price-to-Book (P/B) Ratio
0.39 2.09 0.39 0.77 0.93
Price-to-Free Cash Flow (P/FCF) Ratio
-0.91 -0.98 -0.91 -2.98 -5.20
Price-to-Operating Cash Flow Ratio
-0.93 -1.00 -0.93 -3.12 -5.50
Price-to-Earnings Growth (PEG) Ratio
0.32 -0.02 0.32 0.17 0.04
Price-to-Fair Value
0.39 2.09 0.39 0.77 0.93
Enterprise Value Multiple
0.57 -0.53 0.57 -0.64 -1.60
Enterprise Value
6.89M 16.65M -11.23M 11.61M 20.78M
EV to EBITDA
-0.85 -0.53 0.57 -0.64 -1.60
EV to Sales
49.23 82.43 -79.65 85.99 127.50
EV to Free Cash Flow
-0.73 -0.76 0.69 -0.80 -1.90
EV to Operating Cash Flow
-0.76 -0.78 0.70 -0.83 -2.00
Tangible Book Value Per Share
0.76 0.16 0.76 1.16 1.88
Shareholders’ Equity Per Share
0.80 0.21 0.80 1.20 1.92
Tax and Other Ratios
Effective Tax Rate
-0.08 0.00 -0.08 -0.12 -0.13
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
-0.44 -0.60 -0.44 -0.45 -0.51
Tax Burden
1.14 1.00 1.08 1.12 1.13
Interest Burden
1.06 0.91 0.98 1.00 1.05
Research & Development to Revenue
33.22 54.15 49.57 56.83 35.09
SG&A to Revenue
50.28 104.64 92.72 64.24 53.09
Stock-Based Compensation to Revenue
6.09 1.20 6.77 11.61 6.36
Income Quality
0.95 0.73 0.83 0.73 0.72
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis